Key result
Early anticoagulation resolves pulmonary thromboembolism in three young men with multidrug-resistant tuberculosis.
Why the study?
Pulmonary thromboembolism in multidrug-resistant tuberculosis further complicates prolonged treatment and increases morbidity and mortality, necessitating physician awareness and early diagnosis.
Case Report (n=3)
Highlights the importance of early diagnosis and management of pulmonary thromboembolism in patients with multidrug-resistant tuberculosis.
Answers are grounded in this paper and cite their sources.
Supports vigilance for pulmonary thromboembolism in multidrug-resistant tuberculosis; leaves open whether early anticoagulation improves outcomes in broader populations.
Background: Pulmonary tuberculosis (PTB) is an established cause of arterial and venous thrombosis. With the rising incidence of multidrug-resistant tuberculosis (MDR TB), which has a prolonged treatment course, pulmonary thromboembolism in such cases further complicates the treatment outcome in terms of mortality and morbidity. TB causes systemic hypercoagulability, which may lead to both arterial and venous thrombosis. Therefore, it is important for treating physicians to be aware of the entity and have a sharp watch for the development of Pulmonary thromboembolism in cases of MDR TB. The Case: We present the association of pulmonary thromboembolism (PTE) with MDR TB in three young males who developed pulmonary thromboembolism during the treatment of MDR TB, along with their management using anticoagulant agents. Conclusion: PTE in cases of TB is rare but fatal. High suspicion of PTE in patients with MDR TB will help in diagnosing the dreaded condition early and aid in reducing preventable mortality with PTE. Early recognition, prompt diagnosis, and management is the key to saving the lives of those with this fatal complication.
No takes yet. Share an insight, caveat, or question.
Marwah et al. (2023) conducted a case report in Multidrug-Resistant Tuberculosis and Pulmonary Thromboembolism (n=3). Anticoagulant therapy was evaluated on Clinical recovery and survival. Early diagnosis and treatment with anticoagulant therapy successfully managed pulmonary thromboembolism in three young male patients with multidrug-resistant tuberculosis.
Synapse has enriched 10 related papers. Consider them for comparative context: